Reuters logo
BRIEF-Oncolys Biopharma says joint research agreement with Juntendo University
November 14, 2017 / 6:47 AM / in 5 days

BRIEF-Oncolys Biopharma says joint research agreement with Juntendo University

Nov 14(Reuters) - Oncolys Biopharma Inc

* Says it signs a joint research agreement with Juntendo University, regarding cancer diagnosis testing drug TelomeScan (OBP-401/OBP-1101)

Source text in Japanese:goo.gl/f7waig

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below